title: BCG vaccine-associated suppurative lymphadenitis.
abstract: Clusters of BCG vaccine-associated suppurative lymphadenitis (BCG-ASLD) have been reported in many countries. We have observed an increase in BCG-ASLD following the change from the percutaneous Evans vaccine to the intradermal BCG Statens Serum Institute (SSI) vaccine.
authors.affiliation: Centre for Child Health, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, 38 New Road, London E1 2AX, UK.
authors.forename: Stephen S S
authors.initials: SS
authors.lastname: Teo
authors.forename: Naima
authors.initials: N
authors.lastname: Smeulders
authors.forename: Delane V
authors.initials: DV
authors.lastname: Shingadia
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D008131:London / Q000453:epidemiology; D008199:Lymphadenitis / Q000453:epidemiology* / Q000209:etiology*; D008297:Male
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine